APA

Pfau M., Fassnacht-Riederle H. M., Freiberg F. J., Wons J. B., Wirth M., Becker M. D. & Michels S. (082016). [Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results]. : Klinische Monatsblatter fur Augenheilkunde.

Chicago

Pfau M, Fassnacht-Riederle H M, Freiberg F J, Wons J B, Wirth M, Becker M D and Michels S. 082016. [Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results]. : Klinische Monatsblatter fur Augenheilkunde.

Harvard

Pfau M., Fassnacht-Riederle H. M., Freiberg F. J., Wons J. B., Wirth M., Becker M. D. and Michels S. (082016). [Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results]. : Klinische Monatsblatter fur Augenheilkunde.

MLA

Pfau M, Fassnacht-Riederle H M, Freiberg F J, Wons J B, Wirth M, Becker M D and Michels S. [Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results]. : Klinische Monatsblatter fur Augenheilkunde. 082016.